Your Family, our business.Watch Video
"I look forward to the day when cord blood collection and storage will be routine practice and stem cell therapy will be the first-line treatment for many of today's incurable diseases."
Tom Moore, co-founder of Cord Blood Registry, has served as the company's CEO since its inception. It is largely due to his leadership and passion for the best technology that CBR has grown into the most experienced, most preferred cord blood bank.
In 1992, when the idea of CBR was born, the concept of storing a newborn’s umbilical cord stem cells for private family use was virtually unheard of. The potential, however, was immense, and today, the company is helping save lives and research cures for conditions that currently are untreatable.
Entrepreneurialism comes naturally to Tom. Prior to founding CBR, he had a well-established career as a successful businessman. He served as founder, chairman, and CEO of SciClone Pharmaceuticals, Inc., the principal of Sand Hill Management Group, and CEO and chairman of Synercom Technology. In addition, Tom held a number of senior management positions at Honeywell, Inc., including VP of Pacific Operations. Tom holds a B.S. in chemical engineering from the University of California, Berkeley, and a B.S. in finance and marketing from California State University, Hayward.
With a strong history in computer technology, pharmaceutical sales, and large-scale operations, Tom always has cutting-edge technology and innovative business models on his radar. One strategy he employed was keeping an "ideas folder" containing articles and other documents with potential as fresh business concepts.
An article from the December 1991 issue of Scientific American sparked the idea that would become Cord Blood Registry, and an opportunity for Tom to start a father/daughter business. Wendy learned that thousands of children died each year waiting for a stem cell match and thought that starting a family bank might help families in need.
The pair did their due diligence, searching out the best stem cell technology and researchers in the world. Their journey led them to the University of Arizona, Tucson, where they paired with Dr. David T. Harris, professor of microbiology and immunology, to start the CBR laboratory. The project began as a pilot partially sponsored by the American Cancer Society and the university. Over the last two decades, CBR has grown into the largest, most well-established family bank in the world.
Tom's engineering background has made him a proponent of quality and continuous improvement. Under his leadership, CBR has helped lead stem cell research and development to better collection, processing, and storage methods. The company is also the exclusive partner with a number of FDA-regulated cord blood stem cell clinical trials, investigating the use of a child's own stem cells to treat a variety of illnesses including hearing loss, cerebral palsy, and traumatic brain injury. This work keeps CBR at the forefront of stem cell medicine.
The industry leader, CBR is constantly striving toward the next level of serving our clients. This mentality has been woven into the fabric of our business since its first days—creating a culture that's focused on the best interest of our client families.